Microsoft outlined how emerging technologies can support diagnosis of rare diseases among children in a report released Feb. 20.
Rare diseases affect almost 350 million people globally, and they can take an average of five years to diagnose, according to the report.
Microsoft set out to combat this issue in 2018, joining forces with Japanese drug developer Takeda and European health alliance Eurodis to launch the Global Commission to End the Diagnostic Odyssey for Children.
